Merck KGaA buys Silence in $1.3B deal after siRNA drug's phase 2 blood cancer win - Fierce Biotech
Source: Fierce Biotech ·
Merck KGaA buys Silence in $1.3B deal after siRNA drug's phase 2 blood cancer win Fierce BiotechGermany's Merck buys Silence Therapeutics in $1.3 billion RNA drug deal ReutersSilence Therapeutics stock soars 125% on Merck acquisition Yahoo FinanceMerck KgaA Is Paying More Than Double for This Gene-Silencing Biotech, Which Is Soaring 125% Barron'sMerck KGaA to Buy Silence Therapeutics for $1.1…